{
  "siteName": "OME Medicine Notes",
  "siteDescription": "Medical education notes from OnlineMedEd videos",
  "notes": [
    {
      "id": "note-0",
      "title": "Welcome to OME Medicine Notes",
      "path": "Welcome.md",
      "folder": null,
      "html": "<h1>Welcome to OME Medicine Notes</h1>\n<p>This is a sample vault to demonstrate the <strong>Obsidian Publisher</strong> features.</p>\n<h2>Features Demonstrated</h2>\n<ul>\n<li><a href=\"#\" class=\"internal-link\" data-note=\"note-2\">Heart Failure</a> - A complete cardiology note</li>\n<li><a href=\"#\" class=\"internal-link\" data-note=\"note-1\">Asthma</a> - A pulmonology note with callouts</li>\n<li>Wikilinks and navigation</li>\n<li>Full-text search (try searching for &quot;BNP&quot; or &quot;albuterol&quot;)</li>\n<li>Dark/light mode toggle</li>\n<li>Export to PDF or Markdown</li>\n</ul>\n<h2>Quick Stats</h2>\n<table>\n<thead>\n<tr>\n<th>Specialty</th>\n<th>Notes Count</th>\n</tr>\n</thead>\n<tbody><tr>\n<td>Cardiology</td>\n<td>1</td>\n</tr>\n<tr>\n<td>Pulmonology</td>\n<td>1</td>\n</tr>\n</tbody></table>\n<h2>Tags</h2>\n<p>Check out notes tagged with <span class=\"tag\" data-tag=\"cardiology\">#cardiology</span> or <span class=\"tag\" data-tag=\"pulmonology\">#pulmonology</span>.</p>\n<hr>\n<div class=\"callout callout-tip\" data-callout-type=\"tip\"><div class=\"callout-title\">TIP: > Use the sidebar to navigate through the folder structure, or use **Cmd/Ctrl + K** to search!</div><div class=\"callout-content\">\n</div></div>\n",
      "content": "\n# Welcome to OME Medicine Notes\n\nThis is a sample vault to demonstrate the **Obsidian Publisher** features.\n\n## Features Demonstrated\n\n- [[Heart Failure]] - A complete cardiology note\n- [[Asthma]] - A pulmonology note with callouts\n- Wikilinks and navigation\n- Full-text search (try searching for \"BNP\" or \"albuterol\")\n- Dark/light mode toggle\n- Export to PDF or Markdown\n\n## Quick Stats\n\n| Specialty | Notes Count |\n|-----------|-------------|\n| Cardiology | 1 |\n| Pulmonology | 1 |\n\n## Tags\n\nCheck out notes tagged with #cardiology or #pulmonology.\n\n---\n\n> [!TIP]\n> Use the sidebar to navigate through the folder structure, or use **Cmd/Ctrl + K** to search!\n"
    },
    {
      "id": "note-1",
      "title": "Asthma",
      "path": "Pulmonology/Asthma.md",
      "folder": "Pulmonology",
      "html": "<h1>Asthma</h1>\n<p>Asthma is a chronic inflammatory disorder of the airways characterized by variable and recurring symptoms, airflow obstruction, bronchial hyperresponsiveness, and underlying inflammation.</p>\n<h2>Pathophysiology</h2>\n<p>The key features are:</p>\n<ol>\n<li><strong>Chronic airway inflammation</strong> - Eosinophils, mast cells, T-lymphocytes</li>\n<li><strong>Bronchial hyperreactivity</strong> - Exaggerated bronchoconstriction</li>\n<li><strong>Reversible airflow obstruction</strong> - Responds to bronchodilators</li>\n</ol>\n<h2>Clinical Features</h2>\n<h3>Symptoms</h3>\n<ul>\n<li>Wheezing (expiratory)</li>\n<li>Shortness of breath</li>\n<li>Chest tightness</li>\n<li>Cough (often nocturnal)</li>\n</ul>\n<div class=\"callout callout-tip\" data-callout-type=\"tip\"><div class=\"callout-title\">TIP: > Symptoms often worse at night or early morning, and triggered by:</div><div class=\"callout-content\">\n- Allergens (dust, pollen, pets)\n- Exercise\n- Cold air\n- Respiratory infections\n</div></div>\n\n<h3>Physical Exam</h3>\n<ul>\n<li>Wheezing on auscultation</li>\n<li>Prolonged expiratory phase</li>\n<li>Use of accessory muscles (severe)</li>\n<li>Nasal polyps (in aspirin-exacerbated disease)</li>\n</ul>\n<h2>Diagnosis</h2>\n<h3>Spirometry (Key Test)</h3>\n<table>\n<thead>\n<tr>\n<th>Parameter</th>\n<th>Findings</th>\n</tr>\n</thead>\n<tbody><tr>\n<td>FEV1</td>\n<td>Reduced</td>\n</tr>\n<tr>\n<td>FVC</td>\n<td>Normal or reduced</td>\n</tr>\n<tr>\n<td>FEV1/FVC</td>\n<td>&lt;0.70 (obstructive pattern)</td>\n</tr>\n<tr>\n<td>Bronchodilator response</td>\n<td>≥12% AND ≥200mL improvement</td>\n</tr>\n</tbody></table>\n<h3>Other Tests</h3>\n<ul>\n<li>Peak flow variability &gt;20%</li>\n<li>Methacholine challenge (if spirometry normal)</li>\n<li>Exhaled nitric oxide (FeNO) - elevated in eosinophilic asthma</li>\n<li>Allergy testing</li>\n</ul>\n<h2>Classification by Severity</h2>\n<pre><code class=\"language-plaintext\">Intermittent:\n  - Symptoms ≤2 days/week\n  - Night symptoms ≤2x/month\n  - FEV1 ≥80% predicted\n\nMild Persistent:\n  - Symptoms &gt;2 days/week (not daily)\n  - Night symptoms 3-4x/month\n  - FEV1 ≥80% predicted\n\nModerate Persistent:\n  - Daily symptoms\n  - Night symptoms &gt;1x/week\n  - FEV1 60-80% predicted\n\nSevere Persistent:\n  - Continuous symptoms\n  - Frequent night symptoms\n  - FEV1 &lt;60% predicted</code></pre><h2>Treatment</h2>\n<h3>Quick-Relief Medications</h3>\n<div class=\"callout callout-important\" data-callout-type=\"important\"><div class=\"callout-title\">IMPORTANT: > **SABA** (Short-Acting Beta-Agonist) is the first-line rescue medication</div><div class=\"callout-content\">\n- Albuterol (salbutamol)\n- Levalbuterol\n</div></div>\n\n<h3>Controller Medications (Stepwise Approach)</h3>\n<p><strong>Step 1</strong>: SABA as needed<br><strong>Step 2</strong>: Low-dose ICS<br><strong>Step 3</strong>: Low-dose ICS + LABA<br><strong>Step 4</strong>: Medium-dose ICS + LABA<br><strong>Step 5</strong>: High-dose ICS + LABA ± add-on therapy<br><strong>Step 6</strong>: Oral corticosteroids + biologics</p>\n<h3>Biologics for Severe Asthma</h3>\n<ul>\n<li><strong>Omalizumab</strong> - Anti-IgE (allergic asthma)</li>\n<li><strong>Mepolizumab/Benralizumab</strong> - Anti-IL-5 (eosinophilic)</li>\n<li><strong>Dupilumab</strong> - Anti-IL-4/13</li>\n</ul>\n<h2>Acute Exacerbation Management</h2>\n<div class=\"callout callout-caution\" data-callout-type=\"caution\"><div class=\"callout-title\">CAUTION: > Signs of life-threatening asthma:</div><div class=\"callout-content\">\n- Silent chest\n- Cyanosis\n- Altered consciousness\n- SpO2 <92%\n</div></div>\n\n<p>Management algorithm:</p>\n<ol>\n<li><strong>Oxygen</strong> - Target SpO2 94-98%</li>\n<li><strong>SABA nebulizer</strong> - q20min x3, then as needed</li>\n<li><strong>Ipratropium</strong> - Add in severe exacerbations</li>\n<li><strong>Corticosteroids</strong> - Prednisone 40-60mg PO (or IV methylpred)</li>\n<li><strong>Consider</strong>: Magnesium sulfate IV, epinephrine</li>\n</ol>\n<h2>Related Notes</h2>\n<ul>\n<li>Back to: <a href=\"#\" class=\"internal-link\" data-note=\"note-2\">Heart Failure</a> for cardiac causes of dyspnea</li>\n<li><a href=\"#\" class=\"internal-link\" data-note=\"note-0\">Welcome</a> for vault overview</li>\n</ul>\n<hr>\n<p><span class=\"tag\" data-tag=\"pulmonology\">#pulmonology</span> <span class=\"tag\" data-tag=\"asthma\">#asthma</span> <span class=\"tag\" data-tag=\"chronic\">#chronic</span></p>\n",
      "content": "\n# Asthma\n\nAsthma is a chronic inflammatory disorder of the airways characterized by variable and recurring symptoms, airflow obstruction, bronchial hyperresponsiveness, and underlying inflammation.\n\n## Pathophysiology\n\nThe key features are:\n\n1. **Chronic airway inflammation** - Eosinophils, mast cells, T-lymphocytes\n2. **Bronchial hyperreactivity** - Exaggerated bronchoconstriction\n3. **Reversible airflow obstruction** - Responds to bronchodilators\n\n## Clinical Features\n\n### Symptoms\n- Wheezing (expiratory)\n- Shortness of breath\n- Chest tightness\n- Cough (often nocturnal)\n\n> [!TIP]\n> Symptoms often worse at night or early morning, and triggered by:\n> - Allergens (dust, pollen, pets)\n> - Exercise\n> - Cold air\n> - Respiratory infections\n\n### Physical Exam\n- Wheezing on auscultation\n- Prolonged expiratory phase\n- Use of accessory muscles (severe)\n- Nasal polyps (in aspirin-exacerbated disease)\n\n## Diagnosis\n\n### Spirometry (Key Test)\n| Parameter | Findings |\n|-----------|----------|\n| FEV1 | Reduced |\n| FVC | Normal or reduced |\n| FEV1/FVC | <0.70 (obstructive pattern) |\n| Bronchodilator response | ≥12% AND ≥200mL improvement |\n\n### Other Tests\n- Peak flow variability >20%\n- Methacholine challenge (if spirometry normal)\n- Exhaled nitric oxide (FeNO) - elevated in eosinophilic asthma\n- Allergy testing\n\n## Classification by Severity\n\n```\nIntermittent:\n  - Symptoms ≤2 days/week\n  - Night symptoms ≤2x/month\n  - FEV1 ≥80% predicted\n\nMild Persistent:\n  - Symptoms >2 days/week (not daily)\n  - Night symptoms 3-4x/month\n  - FEV1 ≥80% predicted\n\nModerate Persistent:\n  - Daily symptoms\n  - Night symptoms >1x/week\n  - FEV1 60-80% predicted\n\nSevere Persistent:\n  - Continuous symptoms\n  - Frequent night symptoms\n  - FEV1 <60% predicted\n```\n\n## Treatment\n\n### Quick-Relief Medications\n\n> [!IMPORTANT]\n> **SABA** (Short-Acting Beta-Agonist) is the first-line rescue medication\n> - Albuterol (salbutamol)\n> - Levalbuterol\n\n### Controller Medications (Stepwise Approach)\n\n**Step 1**: SABA as needed\n**Step 2**: Low-dose ICS\n**Step 3**: Low-dose ICS + LABA\n**Step 4**: Medium-dose ICS + LABA\n**Step 5**: High-dose ICS + LABA ± add-on therapy\n**Step 6**: Oral corticosteroids + biologics\n\n### Biologics for Severe Asthma\n- **Omalizumab** - Anti-IgE (allergic asthma)\n- **Mepolizumab/Benralizumab** - Anti-IL-5 (eosinophilic)\n- **Dupilumab** - Anti-IL-4/13\n\n## Acute Exacerbation Management\n\n> [!CAUTION]\n> Signs of life-threatening asthma:\n> - Silent chest\n> - Cyanosis\n> - Altered consciousness\n> - SpO2 <92%\n\nManagement algorithm:\n1. **Oxygen** - Target SpO2 94-98%\n2. **SABA nebulizer** - q20min x3, then as needed\n3. **Ipratropium** - Add in severe exacerbations\n4. **Corticosteroids** - Prednisone 40-60mg PO (or IV methylpred)\n5. **Consider**: Magnesium sulfate IV, epinephrine\n\n## Related Notes\n- Back to: [[Heart Failure]] for cardiac causes of dyspnea\n- [[Welcome]] for vault overview\n\n---\n\n#pulmonology #asthma #chronic\n"
    },
    {
      "id": "note-2",
      "title": "Heart Failure",
      "path": "Cardiology/Heart Failure.md",
      "folder": "Cardiology",
      "html": "<h1>Heart Failure</h1>\n<p>Heart failure (HF) is a clinical syndrome caused by structural or functional cardiac abnormalities resulting in reduced cardiac output and/or elevated intracardiac pressures.</p>\n<h2>Classification</h2>\n<h3>By Ejection Fraction</h3>\n<ul>\n<li><strong>HFrEF</strong> (Reduced EF): EF ≤40%</li>\n<li><strong>HFmrEF</strong> (Mildly Reduced EF): EF 41-49%</li>\n<li><strong>HFpEF</strong> (Preserved EF): EF ≥50%</li>\n</ul>\n<h3>By Timing</h3>\n<ul>\n<li><strong>Acute HF</strong>: Rapid onset of symptoms</li>\n<li><strong>Chronic HF</strong>: Progressive, long-term condition</li>\n</ul>\n<h2>Etiology</h2>\n<ol>\n<li><strong>Ischemic heart disease</strong> (most common)</li>\n<li>Hypertension</li>\n<li>Valvular disease</li>\n<li>Cardiomyopathies</li>\n<li>Arrhythmias</li>\n</ol>\n<h2>Clinical Features</h2>\n<div class=\"callout callout-important\" data-callout-type=\"important\"><div class=\"callout-title\">IMPORTANT: > Remember the classic presentation:</div><div class=\"callout-content\">\n- **Left-sided failure**: Dyspnea, orthopnea, PND, pulmonary edema\n- **Right-sided failure**: JVD, peripheral edema, hepatomegaly\n</div></div>\n\n<h3>Symptoms</h3>\n<ul>\n<li>Dyspnea on exertion</li>\n<li>Orthopnea (need to sleep with pillows)</li>\n<li>Paroxysmal nocturnal dyspnea (PND)</li>\n<li>Fatigue</li>\n<li>Lower extremity edema</li>\n</ul>\n<h3>Signs</h3>\n<ul>\n<li>Elevated JVP</li>\n<li>S3 gallop (volume overload)</li>\n<li>Pulmonary crackles</li>\n<li>Peripheral edema</li>\n<li>Hepatomegaly</li>\n</ul>\n<h2>Diagnosis</h2>\n<h3>Labs</h3>\n<table>\n<thead>\n<tr>\n<th>Test</th>\n<th>Finding in HF</th>\n</tr>\n</thead>\n<tbody><tr>\n<td>BNP</td>\n<td>&gt;100 pg/mL suggests HF</td>\n</tr>\n<tr>\n<td>NT-proBNP</td>\n<td>&gt;300 pg/mL in acute setting</td>\n</tr>\n<tr>\n<td>Troponin</td>\n<td>May be elevated in acute HF</td>\n</tr>\n</tbody></table>\n<h3>Imaging</h3>\n<ul>\n<li><strong>Echocardiogram</strong>: Gold standard for EF assessment</li>\n<li><strong>CXR</strong>: Cardiomegaly, pulmonary congestion</li>\n<li><strong>Cardiac MRI</strong>: For detailed structural assessment</li>\n</ul>\n<h2>Treatment</h2>\n<h3>Acute Management</h3>\n<pre><code class=\"language-plaintext\">1. Position: Sit patient upright\n2. Oxygen: Target SpO2 ≥94%\n3. Diuretics: IV furosemide 40-80mg\n4. Vasodilators: Nitrates if BP adequate\n5. Consider: Inotropes if cardiogenic shock</code></pre><h3>Chronic HFrEF (Four Pillars of Therapy)</h3>\n<div class=\"callout callout-note\" data-callout-type=\"note\"><div class=\"callout-title\">NOTE: > Guideline-directed medical therapy (GDMT) includes four classes of drugs that reduce mortality:</div><div class=\"callout-content\">\n</div></div>\n\n<ol>\n<li><strong>ACE inhibitor/ARB/ARNI</strong> - Start low, titrate up</li>\n<li><strong>Beta-blocker</strong> (carvedilol, metoprolol succinate, bisoprolol)</li>\n<li><strong>Mineralocorticoid receptor antagonist</strong> (spironolactone, eplerenone)</li>\n<li><strong>SGLT2 inhibitor</strong> (dapagliflozin, empagliflozin)</li>\n</ol>\n<h3>Device Therapy</h3>\n<ul>\n<li><strong>ICD</strong>: For EF ≤35% after 3 months of GDMT</li>\n<li><strong>CRT</strong>: For EF ≤35% + LBBB + QRS ≥150ms</li>\n</ul>\n<h2>Prognosis</h2>\n<div class=\"callout callout-warning\" data-callout-type=\"warning\"><div class=\"callout-title\">WARNING: > 5-year mortality is approximately 50% after diagnosis. Early GDMT initiation is crucial!</div><div class=\"callout-content\">\n</div></div>\n\n<h2>Related Notes</h2>\n<ul>\n<li>See also: <a href=\"#\" class=\"internal-link\" data-note=\"note-1\">Asthma</a> for pulmonary differential</li>\n</ul>\n<hr>\n<p><span class=\"tag\" data-tag=\"cardiology\">#cardiology</span> <span class=\"tag\" data-tag=\"HF\">#HF</span> <span class=\"tag\" data-tag=\"acute\">#acute</span></p>\n",
      "content": "\n# Heart Failure\n\nHeart failure (HF) is a clinical syndrome caused by structural or functional cardiac abnormalities resulting in reduced cardiac output and/or elevated intracardiac pressures.\n\n## Classification\n\n### By Ejection Fraction\n- **HFrEF** (Reduced EF): EF ≤40%\n- **HFmrEF** (Mildly Reduced EF): EF 41-49%\n- **HFpEF** (Preserved EF): EF ≥50%\n\n### By Timing\n- **Acute HF**: Rapid onset of symptoms\n- **Chronic HF**: Progressive, long-term condition\n\n## Etiology\n\n1. **Ischemic heart disease** (most common)\n2. Hypertension\n3. Valvular disease\n4. Cardiomyopathies\n5. Arrhythmias\n\n## Clinical Features\n\n> [!IMPORTANT]\n> Remember the classic presentation:\n> - **Left-sided failure**: Dyspnea, orthopnea, PND, pulmonary edema\n> - **Right-sided failure**: JVD, peripheral edema, hepatomegaly\n\n### Symptoms\n- Dyspnea on exertion\n- Orthopnea (need to sleep with pillows)\n- Paroxysmal nocturnal dyspnea (PND)\n- Fatigue\n- Lower extremity edema\n\n### Signs\n- Elevated JVP\n- S3 gallop (volume overload)\n- Pulmonary crackles\n- Peripheral edema\n- Hepatomegaly\n\n## Diagnosis\n\n### Labs\n| Test | Finding in HF |\n|------|---------------|\n| BNP | >100 pg/mL suggests HF |\n| NT-proBNP | >300 pg/mL in acute setting |\n| Troponin | May be elevated in acute HF |\n\n### Imaging\n- **Echocardiogram**: Gold standard for EF assessment\n- **CXR**: Cardiomegaly, pulmonary congestion\n- **Cardiac MRI**: For detailed structural assessment\n\n## Treatment\n\n### Acute Management\n```\n1. Position: Sit patient upright\n2. Oxygen: Target SpO2 ≥94%\n3. Diuretics: IV furosemide 40-80mg\n4. Vasodilators: Nitrates if BP adequate\n5. Consider: Inotropes if cardiogenic shock\n```\n\n### Chronic HFrEF (Four Pillars of Therapy)\n\n> [!NOTE]\n> Guideline-directed medical therapy (GDMT) includes four classes of drugs that reduce mortality:\n\n1. **ACE inhibitor/ARB/ARNI** - Start low, titrate up\n2. **Beta-blocker** (carvedilol, metoprolol succinate, bisoprolol)\n3. **Mineralocorticoid receptor antagonist** (spironolactone, eplerenone)\n4. **SGLT2 inhibitor** (dapagliflozin, empagliflozin)\n\n### Device Therapy\n- **ICD**: For EF ≤35% after 3 months of GDMT\n- **CRT**: For EF ≤35% + LBBB + QRS ≥150ms\n\n## Prognosis\n\n> [!WARNING]\n> 5-year mortality is approximately 50% after diagnosis. Early GDMT initiation is crucial!\n\n## Related Notes\n- See also: [[Asthma]] for pulmonary differential\n\n---\n\n#cardiology #HF #acute\n"
    }
  ],
  "folderTree": {
    "name": "root",
    "children": [
      {
        "name": "Pulmonology",
        "path": "Pulmonology",
        "children": [],
        "notes": [
          {
            "id": "note-1",
            "title": "Asthma"
          }
        ]
      },
      {
        "name": "Cardiology",
        "path": "Cardiology",
        "children": [],
        "notes": [
          {
            "id": "note-2",
            "title": "Heart Failure"
          }
        ]
      }
    ],
    "notes": [
      {
        "id": "note-0",
        "title": "Welcome to OME Medicine Notes"
      }
    ]
  }
}